To find the most relevant journal, please insert appropriate keyword to facilitate search.
Search Results: CPB
Current Pharmaceutical Biotechnology
ISSN: 1389-2010 (Print)
eISSN: 1873-4316 (Online)
- DNA/protein engineering and processing
- Synthetic biotechnology
- Omics (genomics, proteomics, metabolomics and systems biology)
- Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
- Drug delivery and targeting
- Nanobiotechnology
- Molecular pharmaceutics and molecular pharmacology
- Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
- Pharmacokinetics and pharmacodynamics
- Applied Microbiology
- Bioinformatics (computational biopharmaceutics and modeling)
- Environmental biotechnology
- Regenerative medicine (stem cells, tissue engineering and biomaterials)
- Translational immunology (cell therapies, antibody engineering, xenotransplantation)
- Industrial bioprocesses for drug production and development
- Biosafety
- Biotech ethics
Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.
Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
Special Issues With Active Call for Papers
Submission closes on: Apr 13, 2025
Machine Learning and Artificial Intelligence for Medical Data Analysis and Human Information Analysis in Healthcare
The intersection of machine learning (ML) and artificial intelligence (AI) with the pharmaceutical industry is revolutionizing traditional paradigms in drug discovery and development. These technologies have introduced innovative approaches to analyzing complex datasets and predicting chemical properties, leading to more efficient identification and optimization of drug candidates. By employing sophisticated algorithms and computational models, AI and ML are enabling the pharmaceutical industry to address critical challenges, thus accelerating the arrival of novel therapies to patients.... see more